***CORONA VIRUS UPDATES***

[Kool_SRG]

India reports over 64,000 new cases, 1,092 deaths in past 24 hours

India on Wednesday reported a spike of 64,531 cases and 1,092 deaths reported in India, in the last 24 hours.The COVID19 tally in the country now rises to 27,67,274 including 6,76,514 active cases, 20,37,871 discharged/migrated & 52,889 deaths.

[Kool_SRG]

Over 8 lakh samples tested yesterday, says ICMR

The Indian Council of Medical Research has tested 3,17,42,782 samples so far, ANI reports. Of this, 8,01,518 samples were tested on Tuesday.

[Kool_SRG]

Pune overtakes Mumbai in number of cases

Pune has reported more number of cases due to a large number of tests being conducted in Pune, which is more than Mumbai. Also, more number of people are being discharged after recovery, said Pune Mayor to ANI.

 

 

[Kool_SRG]

Global COVID-19 total rises to 2,2 crore; toll at 7.78 lakh

Globally, the corona virus has infected 2,20,46,135 people and claimed 7,78,557 lives, according to the Johns Hopkins University’s tracker. More than 1.4 crore people have recovered from the infection so far.

[Kool_SRG]

Nearly 50 lakh salaried persons lost their jobs in July, says report

Nearly 50 lakh salaried persons lost their jobs in July, the Centre for Monitoring Indian Economy has said. This was the impact of a continuing partial lock down imposed to combat the corona virus pandemic. India began its “Unlock” procedure on 1 June, to restart all economic activities.

The number of jobs lost in July paled in comparison with April, when 1.77 crore salaried individuals fell out of work. However, the job loss in July was higher than the 10 lakh jobs lost in May. In June, salaried persons actually gained 39 lakh jobs, however, the net result of the last four months is that 1.89 crore salaried individuals are out of work, reports Scroll.in

[Kool_SRG]

Oxford-AstraZeneca vaccine may be the first shot available in India by 2020-end

India looks for Oxford-AstraZeneca vaccine candidate to be the likely first shot available for Indians by the end of 2020, reported Times of India.

The Pune-based Serum Institute, manufacturing Oxford-AstraZeneca vaccine, has started advanced phases of human trial (Phase 2 and 3) in India with around 1,600 people aged above 18 years in across 17 selected sites across the country.

Whereas, the other two indigenously developed vaccine candidates — Bharat Biotech's Covaxin, jointly developed with ICMR, and Zydus Cadila’s Zycov D are both in early phases 1 and 2.

[Kool_SRG]

[Kool_SRG]

India reports highest single-day spike of nearly 70,000 cases

India reports 69,652 cases in 24 hours, taking the tally to 28,36,925. The toll increases by 977 to 53,866. There are now 6,86,395 active cases, while as many as 20,96,664 people have been discharged after undergoing treatment so far.

 

 

[Kool_SRG]

Global COVID-19 total rises to 2.2 crores; toll at 7.84 lakh

The global corona virus tally rose to 2,22,62,946 while the toll crossed 7.84 lakh, according to the Johns Hopkins University’s tracker. More than 1.42 crore people have recovered from the infection so far.

[Kool_SRG]

More than 9 lakh tests done in the past 24 hours

According to the Ministry of Health and Family Welfare, more than 9 lakh COVID19 tests conducted in the last 24 hours, while the positivity rate drops to 8 percent.

[Kool_SRG]

India's COVID-19 recovery rate rises to 73.9%; case fatality at 1.9%

India's COVID-19 caseload went past 28 lakh with a record single-day spike of 69,652 infections, while the recoveries increased to 20,96,664 on Thursday pushing the recovery rate to 73.91 percent, according to the Union Health Ministry data.

The total cases of corona virus infections mounted to 28,36,925, while the death toll climbed to 53,866 with 977 new fatalities being reported in a day, the data updated at 8 am showed. Case fatality rate has declined to 1.90 per cent.

 

[Kool_SRG]

[Kool_SRG]

[Kool_SRG]

[Kool_SRG]